We are live on
!
Find out more
PSC
Prentiss Smith & Co Portfolio holdings
AUM
$182M
1-Year Est. Return
26.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.92%
AUM
$195M
AUM Growth
-$15M
(-7.2%)
Cap. Flow
-$23.6M
Cap. Flow
% of AUM
-12.1%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
80
New
3
Increased
10
Reduced
36
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$3.91M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$2.39M |
| 3 |
Simpson Manufacturing
SSD
|
+$2.02M |
| 4 |
Becton Dickinson
BDX
|
+$1.2M |
| 5 |
AGR
Avangrid, Inc.
AGR
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idacorp
IDA
|
+$6.39M |
| 2 |
Medtronic
MDT
|
+$5.34M |
| 3 |
Brady Corp
BRC
|
+$5.17M |
| 4 |
Peloton Interactive
PTON
|
+$2.45M |
| 5 |
US Bancorp
USB
|
+$2.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.07% |
| 2 | Consumer Staples | 19.54% |
| 3 | Technology | 17.89% |
| 4 | Communication Services | 10.65% |
| 5 | Financials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.19T
| $10M | 5.16% |
97,020
-3,620
| -4% | -$359K |
|
2
Johnson & Johnson
JNJ
$646B
| $9.33M | 4.79% |
56,750
-909
| -2% | -$147K |
|
3
Verizon
VZ
$208B
| $7.88M | 4.05% |
135,533
-234
| -0.2% | -$13.2K |
|
4
Church & Dwight Co
CHD
$24B
| $7.75M | 3.98% |
88,661
-1,206
| -1% | -$101K |
|
5
Allot
ALLT
$381M
| $7.31M | 3.76% |
457,623
-150,716
| -25% | -$2.2M |
|
6
Cerence
CRNC
$384M
| $6.96M | 3.57% |
77,647
+134
| +0.2% | +$14.7K |
|
7
General Mills
GIS
$22.2B
| $6.94M | 3.57% |
113,180
+7,472
| +7% | +$431K |
|
8
Hershey
HSY
$36B
| $6.67M | 3.43% |
42,190
-375
| -0.9% | -$56.5K |
|
9
Revvity
RVTY
$14.4B
| $6.37M | 3.27% |
49,650
-2,342
| -5% | -$324K |
|
10
Salesforce
CRM
$211B
| $6.25M | 3.21% |
29,502
+595
| +2% | +$132K |
|
11
Abbott
ABT
$195B
| $6.07M | 3.12% |
50,645
-986
| -2% | -$117K |
|
|
AGR
12
DELISTED
Avangrid, Inc.
AGR
| $6.03M | 3.1% |
121,086
+22,084
| +22% | +$1.04M |
|
13
T. Rowe Price
TROW
$23.7B
| $5.62M | 2.89% |
32,745
-11,138
| -25% | -$1.83M |
|
|
14
Regeneron Pharmaceuticals
REGN
$81.8B
| $5.56M | 2.86% |
11,744
+4,916
| +72% | +$2.39M |
|
|
CERN
15
DELISTED
Cerner Corp
CERN
| $5.51M | 2.83% |
76,619
-10,940
| -12% | -$822K |
|
|
16
Peloton Interactive
PTON
$2.39B
| $5.41M | 2.78% |
48,111
-18,457
| -28% | -$2.45M |
|
17
Hyster-Yale Materials Handling
HY
$609M
| $5.09M | 2.62% |
58,421
-20,093
| -26% | -$1.76M |
|
18
Novartis
NVS
$292B
| $4.96M | 2.55% |
57,986
-6,919
| -11% | -$621K |
|
19
Cisco
CSCO
$433B
| $4.73M | 2.43% |
91,433
-863
| -0.9% | -$40.5K |
|
20
Procter & Gamble
PG
$334B
| $4.36M | 2.24% |
32,209
| – | – |
|
|
21
Dentsply Sirona
XRAY
$2.22B
| $4.31M | 2.21% |
+67,495
| New | +$3.91M |
|
22
Colgate-Palmolive
CL
$72.3B
| $4.18M | 2.15% |
53,056
-953
| -2% | -$74.7K |
|
23
Tennant Co
TNC
$1.19B
| $4.14M | 2.13% |
51,775
+6,806
| +15% | +$516K |
|
24
Unilever
UL
$140B
| $3.85M | 1.98% |
61,364
-858
| -1% | -$54.6K |
|
25
Mitek Systems
MITK
$851M
| $3.56M | 1.83% |
244,171
-5,886
| -2% | -$94.5K |
|
Similar funds
TA
LAM
MPW
SRB
BFP
FNBOH
SIM
CAM
Prentiss Smith & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Prentiss Smith & Co held 80 positions worth $195M, down 7.2% from $210M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Prentiss Smith & Co withdrew a net $23.6M in Q1 2021, closing 6 positions and reducing 36 holdings. Its most notable exit was Brady Corp, an estimated $5.17M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Prentiss Smith & Co opened a new position in Dentsply Sirona worth $4.31M.
- Prentiss Smith & Co's largest Q1 2021 buy was Dentsply Sirona: 67,495 shares worth $4.31M.
- Prentiss Smith & Co added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $2.39M increase.
- Prentiss Smith & Co's biggest Q1 2021 reduction was Idacorp, cutting an estimated $6.39M.
- Prentiss Smith & Co fully exited Brady Corp in Q1 2021, selling an estimated $5.17M.
- Prentiss Smith & Co's ten largest holdings make up 39% of its $195M portfolio in Q1 2021.
- Prentiss Smith & Co opened 3 new positions and closed 6 in Q1 2021.
- Prentiss Smith & Co's portfolio value fell 7.2% quarter-over-quarter to $195M.
Based on Prentiss Smith & Co's 13F filing for Q1 2021, filed 21 Jun 2021.